Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial

Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial

<p>Abstract</p> <p>Background</p> <p>The purpose of this study is to assess the predictive accuracy of a multi-gene predictor of response to docetaxel, 5-fluorouracil, epirubicin and cyclophosphamide combination chemotherapy on gene expression data from patients who rec...

Full description

Bibliographic Details
Main Authors: Shen Kui, Qi Yuan, Song Nan, Tian Chunqiao, Rice Shara D, Gabrin Michael J, Brower Stacey L, Symmans William Fraser, O’Shaughnessy Joyce A, Holmes Frankie A, Asmar Lina, Pusztai Lajos
Format: Article
Language:English
Published: BMC 2012-11-01
Series:BMC Medical Genomics
Subjects:
Multi-gene predictor of chemosensitivity
Breast cancer
Cell lines
Online Access:http://www.biomedcentral.com/1755-8794/5/51

Internet

http://www.biomedcentral.com/1755-8794/5/51

Similar Items